These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6094791)

  • 1. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD; Broussolle EP; London ED
    J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.
    Compton DR; Bagley RB; Katzen JS; Martin BR
    Life Sci; 1987 Jun; 40(22):2195-206. PubMed ID: 3035304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
    Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
    J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.
    Su TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):284-90. PubMed ID: 6290634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of non-opioid sigma binding with (d)3H-SKF 10047 in guinea pig brain.
    Mickelson MM; Lahti RA
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):255-63. PubMed ID: 2986252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
    Balster RL
    J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
    Kushner L; Zukin SR; Zukin RS
    Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
    Steinfels GF; Tam SW; Cook L
    Psychopharmacology (Berl); 1987; 91(1):5-9. PubMed ID: 3029793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
    Samovilova NN; Iarygin KN; Vinogradov VA
    Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of kappa- and sigma-opiates in rat brain.
    Wolozin BL; Nishimura S; Pasternak GW
    J Neurosci; 1982 Jun; 2(6):708-13. PubMed ID: 6283040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.